Coronavirus – Merck Pill: Early February WHO recommendation


A World Health Organization official says a recommendation for Merck antiviral pill is possible by early February.

Janet Dias, head of clinical management at the WHO, also said that the WHO Instruction Development Team is also being prepared to Pfizer Pill?

“We will look at this data (for the Pfizer pill) in early February for publication possibly later that month.”

The committee recommended the use of two drugs by Eli Lilly and GlaxoSmithKline and Vir Biotechnology for patients with COVID-19, increasing treatment options but Omicron makes some of them less effective.

Regarding monoclonal antibodies, he noted that some of them show less neutralization against the highly contagious Omicron and may be less effective against this variant.

However, he said that he did not “brings upside down”, As well as many treatment options are now available.

“We are monitoring the antivirals for the development of resistance”, added the WHO official.

Today, the platform was opened in Greece for the administration of the Merck pill to patients with coronavirus who are being treated at home, with the Deputy Minister of Health, Mina Gaga, stating that it will be administered under the responsibility of the patient.

See also: Papageorgiou: 55 women with Covid-19 gave birth and their babies did not get coronavirus  

Leave A Reply

Your email address will not be published.